Abstract. The purpose of the present study was to investigate the influence of lack of histamine (HA) on tumor growth and functions of T cells in order further to illustrate the mechanism of immunological tolerance induction by HA. We assessed the phenotype and cytokine production of splenic lymphocytes in syngeneic HA-free (histidine decarboxylase knock-out) (HDC KO) and wild-type mice, inoculated subcutaneously with the LM2 murine breast cancer cell line. Relative quantification of target mRNA was performed with a TaqMan real-time RT-PCR assay. The CD4 +
Introduction
The progressive growth of tumors in mice is accompanied by a down-regulation of specific T cell responses. The factors involved in this suppression are not completely understood. Here, we have developed a model to examine the role of histamine-producing host cells in the inhibition of T cell function.
Histamine affects the maturation of cells of the immune system and alters their activation, polarization, chemotaxis, and effector functions (1) . Histamine also regulates antigen-specific T helper (Th) 1 and Th2 cells by shifting cytokine production from a Th1 to a Th2 pattern, as well as modifying the related antibody isotype responses (2) . Histamine binds to four different G protein-coupled receptors that transduce signals to cells through distinct pathways. The expression of these receptors on different cells and cell subsets is regulated, and apparently, the diverse effects of histamine on immune regulation are due to differential expression of 4 histamine receptors and their distinct intracellular signals (3, 4) .
Histamine can facilitate the development of a Th2 immune response by inhibiting the production of interleukin (IL)-12 and promoting the production of IL-10 by antigen-presenting cells (APC). Modulation of IL-12 and IL-10 secretion by histamine involves the H 2 and H 3 receptors of dendritic cells (5) . Using a mouse peripheral blood mononuclear cell (PBMC) culture system, it was demonstrated that histamine was a potent inductor of IL-12 and also of interferon (IFN)-γ (6) .
Polarization of an immune response from the Th1 towards the Th2 phenotype contributes to decreased cellular immunity against cancer; and in this condition, the tumor-infiltrating cells produce more IL-4, IL-5, IL-10, and IL-13 and less IFN-γ, tumor necrosis factor (TNF)-β, and IL-2 (7, 8) . Infiltration by lymphocytes, macrophages, mast cells, and neutrophils is a hallmark of inflammatory, defense and tissue repair reactions, which are often present in tumors. Various types of tumor-infiltrating macrophages and lymphocytes, including cytotoxic T cells, natural killer cells, and lymphokine-activated killer cells, are considered as potential effectors of antitumor immunity and may interfere with tumor expansion (9) .
The inhibitory activity of regulatory T (Treg) cells is considered to be central in the prevention of autoimmune and chronic inflammatory diseases (10) . This finding suggests that Tregs, which protect against autoimmunity, may also mitigate the immune response against cancers. There are two major categories of Treg cells described to date (11, 12) . Recently, the fork head / winged helix transcription factor gene Foxp3 has been shown to program CD4 +
CD25
+ T cell development and function (13).
The role of histamine in tumor development (14) has already been demonstrated and the involvement of histamine in colon tumor cell growth has also been established. Also this function was postulated in the multistage model of carcinogenesis in association with inflammatory responses (15) . Histamine can influence the activity of cytotoxic T lymphocytes and promote tumor formation. Further studies of histamine receptor profiles on the tumor cells and the actions of histamine through its various receptors may open new therapeutic ways to treat histamine-dependent tumors In addition, there is increasing evidence that supports the immunomodulatory roles of histamine under different cytokine environments (16) . The immunomodulatory effects of histamine include the regulation of cytotoxic T-cell activity (17) , the enhancement of NK cell activity (18) , and the regulation of cytokine production in human PBMC (19) . The availability of a histidine decarboxylase (HDC) −/ − (HDC KO) mouse (20) provides a comprehensive model to study the molecular details of the interaction of histamine and the immune system. In the present work, we studied the effect of histamine deficiency on tumor growth and cytokine production of lymphocytes.
This study combined with other indirect evidences has led us to formulate the hypothesis that the histamineinduced invasion of tumor cells in mice is associated with an expansion of Treg cells that suppress the tumorspecific immune response.
Materials and Methods

Mice
The generation and genotyping of HDC KO mice has been described previously (20) . Generation of HDC gene-targeted mice has been described using R1 embryonic stem (ES) cells. Both homozygous HDC-deficient (HDC KO) and wild-type (HDC WT) animals were littermates in a segregating F2 population. Two-monthold male wild type and HDC KO mice (BALB / c background) were used in all experiments. All animals were housed under specific pathogen-free conditions.
Tumor-growth
Mice (6 -7 mice in each group) were anesthetized with an intraperitoneal injection of a combination of 44 mg / kg ketamine and 10 mg / kg xylazine. LM-2 cells (3 × 10
5
) were injected to the right flank in 50 µl PBS using a 26-gauge needle attached to a syringe (Hamilton, Germany). Cells were washed with RPMI 1640 medium without FCS and then with PBS before the injection. The two highest perpendicular diameters of s.c. tumors were measured using a caliper 2 -3 times / week. These two diameters of each tumor were multiplied and the product was used as an estimate of the growth area. Data were expressed as the mean ± S.D. for each group of animals at a given time point. Student's t-test was used to compare data of HDC −/ − (KO) and HDC +/ + (WT) mice. All statistics were analyzed using Excel Software 2000, and P values <0.05 were considered statistically significant.
Quantitative real-time RT-PCR
Total RNA was extracted from tumor tissues or spleen cells using TRI-reagent (Sigma-Aldrich Co., St. Louis, MO, USA). Isolated RNA was used as a template for the production of first strand cDNA using random hexamers. Relative quantification of target mRNA was performed with a TaqMan real-time RT-PCR assay on an ABI PRISM 7000 Sequence Detector (Applied Biosystems, ABI; Foster City, CA, USA). Fluorescence emission of the reporter dye is quenched by the quencher dye until nuclease degradation by Taq polymerase during the extension phase of the PCR separates the 2 dyes and enables detection of the reporter dye fluorescence. The threshold cycle (Ct) is defined as the fractional cycle number at which the reporter fluorescence reaches 10× the standard deviation of the baseline. forkhead box P3 (FoxP3). All reactions were set up in triplicates and repeated once. Analyses of real-time quantitative PCR data were performed using the comparative Ct method as suggested by ABI. Ct values are defined as the PCR amplification cycle in which the reporter signal is greater than the minimal detection level, and Ct is inversely related to the relative abundance of a particular transcript. During PCR, the template DNA quantity doubled at each cycle. Therefore, the target quantity X target at threshold cycle C T is given by:
The relative expression of different mRNAs was determined by relative quantification ∆C T = C T target − C T HGPRT using hypoxanthine phosphoribosyltransferase (HGPRT) as a reference gene.
Measurement of cytokine production by ELISA
Splenocytes were prepared from BALB / c mice at 26 days (when tumors have a mean diameter of 1500 mm 3 ) after tumor inoculation. The cells were suspended in RPMI 1640 medium, supplemented with 10% heat-inactivated FCS, 2 mM glutamine, 100 U / ml penicillin, and 100 µg / ml streptomycin. Then, 5 × 10 6 cells/ ml of these cells were stimulated with 5 µg / ml ConA (Sigma-Aldrich, St. Louis, MO, USA) in a 24-well tissue culture plate and incubated for 24 h at 37°C in 5% CO 2 . The culture supernatant was stored at −80°C until use for ELISA assays. The amounts of IL-10, IL-12, IFN-γ, and IL-13 were measured by an ELISA kit (R&D Systems, Minneapolis, MN, USA).
Immunofluorescence labeling and flow cytometry
Lymphocytes were isolated from the spleen and were used for two-and three-color cell surface labeling using Abs against CD3, CD8, CD4, and CD25. All Abs were purchased from BD PharMingen (BD Biosciences, Franklin Lakes, NJ, USA). Labeled cells were analyzed by using FACSCalibur flow cytometer and CellQuest software (BD Biosciences). For each sample, an isotypecontrol was used to determine the positive and negative cell populations. The P values were determined by Student's t-test.
Results
Tumorigenicity of LM2 breast adenocarcinoma cells in HDC KO mice
It was necessary to determine whether host-derived histamine also affects the in vivo growth patterns of experimental tumors. LM2 tumor cells, injected subcutaneously into the flank region of syngeneic BALB / c mice, developed into single solid tumors over the course of the experiment. The mean tumor volume was smaller in the HDC KO mice; that is, at day 26, the tumors were 2666.27 ± 661 mm 3 in the control mice, but only 1530.87 ± 802 mm 3 in the HDC KO animals (P<0.05). Moreover, at day 32, controls reached 4280.9 ± 713 mm 3 while HDC KO mice had only 1828.8 ± 461 mm 3 (P<0.05).
In HDC KO mice, tumors developed slower and remained smaller compared to tumors in WT BALB / c mice (Fig. 1) . It seems that host-derived histamine is important for the growth of LM2 breast cancer cells. Statistically significant differences were observed after day 26.
Immunophenotyping by flow cytometry
Then, we analyzed the T cells from tumor-bearing HDC −/ − (KO) and HDC +/ + (WT) animals by flow cytometry after cell surface labeling for co-expression of + molecules. Three-color FACS analysis was performed on mononuclear cells (Fig. 2) The highest Treg cell numbers were observed in the wild-type tumor-bearing mice (Fig. 2) ; the CD4 / CD8 ratio did not change significantly.
T-bet, Fox-P3, and cytokine expression in splenocytes
Murine experiments have demonstrated that naive CD4 + helper T cells (Th) can develop into at least four types of committed helper T cells, namely, T helper 1 (Th1), Th2, Th17, and regulatory T cells (Tregs). Once differentiated, each lineage is characterized by its own cytokine profile with IFN-γ being the signature cytokine of Th1 cells; IL-4 being the archetypal cytokine of Th2 cells; transcription factors T-bet for Th1 (21); and FoxP3 for Tregs (22) .
We compared the expression of T-bet (T-bet message is the marker of Th1 cells), Foxp3 (Foxp3 is a marker of Treg cells), and cytokine mRNAs in splenocytes of tumor-bearing mice to that of normal mice. Both are higher in splenocytes of KO than in WT normal mice. Level of Fox-P3 decreased significantly and the copies of splenic T-bet mRNA were significantly higher in high+ within CD3 + cell population, which were found to be significantly affected by histamine producing ability (statistics by Student's t-test). These are the splenic T cell compositions of the HDC KO and HDC wild type mice (n = 8). In-group N, the cells were isolated from non-tumor bearing animals, while in-group T, they were derived from tumorbearing mice. Asterisks indicate the groups between which significant difference was found (*P<0.05). HDC KO tumor-bearing mice than those of normal mice (Fig. 3) .
To determine whether the lack of histamine of tumorbearing mice induces alteration of cytokine expression of T-helper subpopulations as well, spleen cells from BALB / c mice were cultured in vitro for 24 h, and the messenger RNA encoding various Th1 / Th2 cytokines was assessed by real-time polymerase chain reaction (Q-RT-PCR). Only IL-4 mRNA was elevated in the tumor-bearing WT mice (WT T) and IL-10, IFN-γ, and IL-12 mRNAs did not change significantly (Fig. 4) .
To determine the protein levels of Th1 / Th2 cytokines in syngeneic LM-2 tumor-bearing mice, IFN-γ, IL-12, IL-10, and IL-13 contents were measured from culture supernatant of splenocytes with ELISA kits on day 26 after tumor inoculation (Fig. 5) . There is no difference between WT and KO mice in the production of IL-10 and IL-13 (control N group), but in LM2 tumor-bearing mice, while the WT genotype results in an increased the production of both cytokines, KO splenocytes are not able to do that. Splenocytes of KO mice produce higher amount of IFN-γ in the steady state, and this difference is maintained rather than increased by the presence of the LM2 tumor. With respect to IL-12, it is interesting that in the WT animals there is a significant decrease by the presence of LM2 tumor, but in the KO mice, starting from a lower level, there is almost no decrease caused by the presence of the tumor, presenting at this point a production level higher that of the WT spleen cells. As shown in Fig. 5 , depletion of histamine resulted in a decrease of the secretion of IL-13 and of IL-10, while it caused an increase in the secretion of IL-12 and IFN-γ from T cells. Non-tumor-bearing mutant mice lacking HDC showed up-regulation of IFN-γ (KO N vs WT N) only that has a slight increase in both WT (WT N vs WT T) and KO (KO N vs KO T) mice, by the presence of the tumor. These results indicated Th2 type cytokine predominance in WT tumor-bearing mice.
Discussion
Here the mechanisms of immunoregulation in the HDC KO transgenic model were studied. Previous studies have demonstrated that effective antitumor responses in breast cancer have been linked to type 1 helper T cells and / or their primary effectors cytokine, IFN-γ (23). The immunomodulatory effects of histamine include the regulation of cytotoxic T-cell activity (17) . Histamine action on H 1 receptor is involved not only in allergic inflammatory reactions but also in augmentation of Th1 responses, whereas the H 2 receptor suppresses Th responses and participates in immune tolerance through IL-10 and transforming growth factor (TGF)-β 24 -26) . In this study, the elevated expression of Th1 cytokines of the HDC KO mice in the tumor microenvironment was demonstrated and that these cytokines originate from the tumor-infiltrating lymphocytes was proposed. IFN-γ, IL-12, and IL-10 are expressed at tumor sites (data not shown), and are not produced by the LM2 tumor cells, and represent critical regulatory factors for cell mediated anti-tumor immunity. Several studies have shown profound inhibition of tumor establishment, growth, and metastasis formation by IL-10. Other studies have suggested that IL-10 may suppress host antitumor responses and promotes tumor growth (27, 28) .
In our experiments in KO mice bearing tumor, Th1 predominance and the decrease of Treg specific transcription factor (Foxp3) were observed. Foxp3 gene expression was reduced and CD4 + CD25 high+ cell number also decreased in KO tumor-bearers compared with the wild-type tumor-bearing mice; however, the highest FoxP3 expression was measured in the control nontumor-bearers group (KO N). We report here that lack of histamine up-regulates T-bet and IL-12 / IFN-γ production. Also, it was reported that isolated dendritic cells, developed in the absence of histamine, indeed exhibit a predominantly Th1-polarized cytokine pattern, as they show elevated levels of IFN-γ upon LPS stimulation (29) .
Here we report that Treg ratio is elevated in the wildtype tumor-bearing animals and the presence of histamine caused a more effective suppression of Th1 cells than inhibition of Th2.
During the last decade, much effort has been made to understand mechanisms by which cancer evades the immune system. It is widely accepted that an immune deviation toward the Th1 response, including induction of CD8 + cytotoxic T cells (CTLs), results in tumor rejection, whereas deviation towards the Th2 response avoids tumor rejection. Among the Th2 cytokines, IL-4 has been demonstrated to be the most critical cytokine to induce Th2 cells (30) . However, recently, the related cytokine IL-13 has been found to play a critical role in a number of pathologic processes, from asthma to parasite-induced fibrosis and antitumor defense (31) . These results are consistent with our observations suggesting that a set of histamine-induced Th2 cytokines would be involved the tumor promotion. Work from our own and other laboratories suggest that histamine-induced IL-13 and IL-10 play a critical role in this down-regulation of tumor immunosurveillance. It is also central to a novel immunoregulatory pathway in which Treg cells are induced by histamine to secrete IL-10, which acts through intermediate cells to suppress CTL responses against the tumor. One possible explanation of this immunosuppression is that skewing the immune response against the tumor toward Th2 will next suppress Th1 immune responses. Previously it was reported that histamine significantly stimulated the growth of Colon 38 colorectal cancer implants in syngeneic mice. It was demonstrated that the exogenous histamine decreased the IFN-γ / IL-4 ratio of peripheral lymphocytes markedly. This cytokine ratio can be taken as an index of the systemic Th1 / Th2 balance in Colon 38-implanted mice (32) .
Histamine also actively participates in functions and activity of dendritic cell (DC) precursors as well as their immature and mature forms (33 -35) . In addition, there is increasing evidence supporting the immunomodulatory effects of histamine on cytokine production in immune cells upon different immunological stimuli (36) . The potential role of histamine in cancer immunotherapy has been a subject of interest for more than a decade. A significant body of research has elucidated the action of histamine in a model system that mimics the tumor microenvironment. In vitro evidence indicates that histamine inhibits the generation and release of reactive oxygen species (ROS) by monocytes / macrophages (MO) during respiratory burst. Since ROS have been shown to abrogate peritumoral and intratumoral cytokine activation of natural killer (NK) and induce apoptosis of these cells in vitro (37) , inhibition of ROS may enable cytokines to activate NK-cells and restore their antineoplastic, cytotoxic capabilities. On the other hand the combination of IL-18 and IL-12 results in a more potent anti-tumor response and NKT cells activated with this combination are essential and collaborate in natural host immunity against the growth of tumors (38, 39) .
In conclusion, the present study demonstrates that endogenous histamine stimulates the growth of breast adenocarcinoma tumor implants in mice by suppressing anti-tumor immunity. Our results suggest that in the absence of histamine or if its effects were avoided, tumors would grow more slowly and this effect would be the consequence of the avoidance of the known switch from Th1 to Th2 that several tumors could produce.
